Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Low-dose Ketamine as Adjuvant Treatment to Morphine in Neuropathic Cancer Pain


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01951911

Organisation Name: Haukeland University Hospital

Overal Status: Withdrawn

Start Date: September 2013

Last Update: July 11, 2017

Lead Sponsor: Haukeland University Hospital

Brief Summary: To see whether the addition of low-dose ketamine to a subcutaneous morphine infusion improves analgesia in patients with neuropathic cancer pain.

Conditions:
  • Pain, Intractable


Total execution time in seconds: 0.15428686141968